Citation: | Shen Wenbin, Zhu Shuchai, Gao Hongmei, Li Juan, Su Jingwei, Liu Zhikun, Li Youmei, Wan Jun. Toxic Effect and Long-term Survival of Three Dimensional Conformal High-dose Radiotherapy for Non- small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(05): 577-581. DOI: 10.3971/j.issn.1000-8578.2012.05.021 |
[1] |
Xiu X,Deng X,Li MY,et al.Clinical analysis of 3DCRT for early stage non-small cell lung cancer[J].Zhonghua Fang She Yi Xue Yu Fang Hu Za Zhi,2007,27(1):73-5.[修霞,邓湘,李明昱,等.早期非小细胞肺癌三维适形放射治疗的疗效[J].中华放射医学与防护杂志,2007,27(1):73-5.]
|
[2] |
Onimaru R,Fujino M,Yamazaki K,et al.Steep dose-response relationship for stage I non-small-celllung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy[J].Int J Radiat Oncol Biol Phys,2008,70(2):374-81.
|
[3] |
Fritz P,Kraus HJ,Blaschke T,et al.Stereotactic,high single-dose irradiation of stage I non-small cell lung cancer(NSCLC) using four-dimensional CT scans for treatment planning[J].LungCancer,2008,60(2):193-9.
|
[4] |
Zhou TC,Lin XD,Cheng Z.Three dimensional conformal hypofractionated hige-dose radiotherapycombined with chemotherapy for stage Ⅲ non-small cell lung cancer[J].Zhong Liu Fang Zhi YanJiu,2004,31(8):498-500.[周同冲,林晓丹,成拯.大分割三维适形放疗联合化疗治疗Ⅲ期非小细胞肺癌疗效分析[J].肿瘤防治研究,2004,31(8):498-500.]
|
[5] |
Tang Q,Yang KY,Wang P,et al.Three dimensional conformal hypofractionated high dose radiotherapycombined with low dose density chemotherapeutic regimen for 72 cases of stage Ⅲ non-small cell lungcancer[J].Zhong Liu Fang Zhi Yan Jiu,2006,33(6):453-4.[唐求,杨坤禹,王鹏,等.大分割三维适形放疗联合低剂量密集式化疗治疗III 期非小细胞肺癌72 例临床分析[J].肿瘤防治研究,2006,33(6):453-4.]
|
[6] |
Etiz D,Marks LB,Zhou SM,et al.Influence of tumor volume on survival in patients irradiated fornon-small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2002,53(4):835-46.
|
[7] |
Rengan R,Rosenzweig KE,Venkatraman E,et al.Improved local control with higher doses ofradiation in large-volume stage III non-small-cell lung cancer[J].Int J Radiat Oncol BiolPhys,2004,60(3):741-7.
|
[8] |
Perez CA,Stanley K,Grundy G,et al.Impact of irradiation technique and tumor extent in tumorcontrol and survival of patients with unresectable non-oat carcinoma of the lung:report by theRadiation Therapy Oncology Group [J].Cancer,1982,50(6):1091-9.
|
[9] |
Belderbos JS,Heemsbergen WD,De Jaeger K,et al.Final results of a Phase I/II dose escalationtrial in non-small cell lung cancer using three-dimensional conformal radiotherapy[J].Int J RadiatOncol Biol Phys,2006,66(1):126-34.
|
[10] |
Choi N,Baumann M,Flentjie M,et al.Predictive factors in radiotherapy for non-small celllung cancer:present status[J].Lung Cancer,2001,31(1):43-56.
|
[11] |
Mehta M,Scrimger R,Mackie R,et al.A new approach to dose escalation in non-small cell lungcancer[J].Int J Radiat Oncol Biol Phys,2001,49(1):23-33.
|
[12] |
Chemotherapy in non-small cell lung cancer:a Meta analysis using update data on individualpatients from 52 randomized clinical trials Non-small cell lung cancer collaborative group[J].BMJ,1995,311(7010):899-909.
|
[13] |
Fournel P,Robinet G,Thomas P,et al.Randomized phase Ⅲ trial of sequential chemoradiotherapycompared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer:GroupeLyon-Saint-Etienne d’Oncologie Thoracique-Groupe Franais de Pneumo-Cancérologie NPC 95-01 Study[J].J Clin Oncol,2005,23(25):5910-7.
|
[14] |
Uitterhoeve AL,Belderbos JS,Koolen MG,et al.Toxicity of high-dose radiotherapy combined withdaily cisplatin in non-small cell lung cancer:results of the EORTC 08912 phase I/II study[J].Eur JCancer,2000,36(5),592-600.
|